0
New
New
2022
Molecular Diagnostics Market

Molecular Diagnostics Market by Type (Instruments, Reagents, Software & Services), by Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Others), by Application (Infectious diseases, Oncology, Genetic testing, Blood screening, Others), by End User (Hospital, Reference Labortories, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

A01840
Pages: 256
Mar 2022 | 19492 Views
Author(s) : Vishal Bhardwaj , Onkar Sumant
Tables: 186
Charts: 67
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Molecular Diagnostics Market

Request Now !

Molecular Diagnostics Market Research, 2030

The Global Molecular Diagnostics Market size was valued at $9.2 billion in 2020, and is projected to reach $23.9 billion by 2030, growing at a CAGR of 9.86% from 2021 to 2030. Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, sub classification, prognosis, and monitoring response to therapy. It is a collection of techniques used to analyze biological markers in the genome and proteome, and how their cells express their genes as proteins, applying molecular biology to medical testing. Molecular diagnostics are widely applied, powerful, and sensitive techniques used to identify biologic markers in a genome and proteome by detecting bacterial genes (with PCR-based techniques) and measuring expressed bacterial infection–specific proteins (with enzyme-linked immunosorbent assay [ELISA] and proteomics).

The COVID-19 pandemic has disrupted workflows in the healthcare sector globally. The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global molecular diagnostics market. The COVID-19 pandemic has stressed the healthcare systems globally and increased the need for the development of diagnostic instruments & diagnostic service centers. Increase in number of COVID-19 cases surged the demand for real time polymerase chain reaction (RT-PCR) test to detect COVID-19.

Get more information on this report : Request Sample Pages

Increase in the prevalence of infectious diseases and various types of cancer drives the growth of the molecular diagnostics market. In addition, increase in awareness and acceptance of personalized medicines, and growth in the biomarker identification further fuel the growth of the market. However, stringent regulatory requirements for the approval of new molecular diagnostics techniques are expected to hinder growth of the market during the forecast period. On the other hand, increase in adoption of the molecular diagnostics in the emerging economies is expected to offer profitable opportunities for the growth of the market during the forecast period.

The COVID-19 pandemic has disrupted workflows in the healthcare sector globally. The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global molecular diagnostics market. The COVID-19 pandemic has stressed the healthcare systems globally and increased the need for the development of diagnostic instruments & diagnostic service centers. Increase in number of COVID-19 cases surged the demand for real time polymerase chain reaction (RT-PCR) test to detect COVID-19. For instance, in 2020, the U.S. Food and Drug Administration authorized an antigen test that is the first over-the-counter fully at-home diagnostic test used for detection of COVID-19. Moreover, in 2020, a total of 646 government laboratories and 247 private laboratories reported to Indian Council of Medical Research (ICMR) for COVID-19 testing. Furthermore, in 2020, the World Health Organization, the Africa Centers for Disease Control and Prevention, the foundation for innovative new diagnostics, the global fund, and the Bill & Melinda Gates foundation announced partnership to provide 120 million affordable quality COVID-19 rapid tests for low and middle income countries. This has significantly contributed toward the growth of the global molecular diagnostics market. Furthermore, increase in adoption of immunoassays and molecular assays diagnostics tests for COVID-19 along with major market player ramping up their R&D activities to curb the COVID-19 pandemic are expected to positively impact the molecular diagnostics market growth.

The molecular diagnostics industry is segmented on the basis of product type, technology, application, end user, and region to provide a detailed assessment of the market. By product type, it is bifurcated into instruments, reagents, and software and services. By technology, it is segmented into polymerase chain reaction (PCR), DNA Sequencing, hybridization, microarray, isothermal nucleic acid amplification technology (INAAT), and other techniques, which include electrophoresis, mass spectroscopy, and flow cytometry. By application, it is divided into infectious diseases, oncology, genetic tests, blood screening, and others include microbiology, cardiovascular diseases, and neurological diseases. On the basis of end user, it is segmented into, hospitals, reference laboratories, and others include blood banks, home health agencies, and nursing homes. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Molecular Diagnostics Market
By Technology

Your browser does not support the canvas element.

By technology, the market is segregated into Polymerase Chain Reaction (PCR), DNA Sequencing, hybridization, microarray, isothermal nucleic acid amplification technology (INAAT), and other techniques, which include electrophoresis, mass spectroscopy, and flow cytometry.

Product Segment

By product type, the market is segmented into instruments, reagents, and software and services. The reagents segment dominated the global market in 2020, and is expected to remain dominant during the forecast period, owing to advancement in R&D activities in pharmaceutical & biotechnology industry, increase in demand for reagents, and surge in adoption of point-of-care testing.

Molecular Diagnostics Market
By Technology

Your browser does not support the canvas element.

By technology, the market is segregated into Polymerase Chain Reaction (PCR), DNA Sequencing, hybridization, microarray, isothermal nucleic acid amplification technology (INAAT), and other techniques, which include electrophoresis, mass spectroscopy, and flow cytometry.

Technology Segment

By technology, the market is segregated into polymerase chain reaction (PCR), DNA Sequencing, hybridization, microarray, isothermal nucleic acid amplification technology (INAAT), and other techniques, which include electrophoresis, mass spectroscopy, and flow cytometry. The polymerase chain reaction segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in application of PCR technology to detect the COVID-19 disease coupled with the rise in launch of molecular diagnostics instruments.

Molecular Diagnostics Market
By Application

Your browser does not support the canvas element.

The market is classified into Infectious diseases, oncology, genetic tests, blood screening, and others include microbiology, cardiovascular diseases, and neurological diseases.

Application Segment

By application, the market is classified into infectious diseases, oncology, genetic tests, blood screening, and others include microbiology, cardiovascular diseases, and neurological diseases. The infectious diseases held the largest market share in 2020, and is expected to remain dominant throughout the forecast period, owing to increase in prevalence of infectious diseases such as SARS-COV-19.

Molecular Diagnostics Market
By Type

Your browser does not support the canvas element.

By product type, the market is segmented into instruments, Reagents, and software and services. The Reagents segment dominated the global market in 2020, and is expected to remain dominant during the forecast period.

End User Segment

By end user, the market is classified into hospitals, reference laboratories, and others include blood banks, home health agencies, and nursing homes. The hospitals segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in the number of patients treated for different infectious diseases, cancer, and others requiring molecular analysis for diagnosis purpose and for quick start of the treatment.

Molecular Diagnostics Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific offers profitable opportunities for key players operating in the molecular diagnostics market, thereby registering the fastest growth rate during the forecast period.

Region Segment

Asia-Pacific offers profitable in molecular diagnostics market opportunity for key players operating in the molecular diagnostics market, thereby registering the fastest growth rate during the forecast period, owing to the growing healthcare infrastructure, rise in disposable incomes, and well-established presence of domestic companies in the region. In addition, higher adoption and increase in use of molecular diagnostics, rapidly growing geriatric population, and rise in incidence of infectious diseases further fuel growth of the market in the region. Moreover, rise in personalized medicine expenditure and a significant increase in the number of well-equipped hospitals with advanced healthcare systems in the region to cater to the needs of the large patient population, drive the growth of the market.

The key market players profiled in the report include F. Hoffmann-La Roche AG, BioMérieux SA, Abbott Laboratories, Becton, Dickinson and Company, Qiagen N.V., Hologic Corporation, Danaher Corporation, S.A., Agilent Inc., Siemens Healthcare GmbH, and Grifols.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the molecular diagnostics market analysis from 2020 to 2030 to identify the prevailing molecular diagnostics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the molecular diagnostics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global molecular diagnostics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Technology
    • Polymerase Chain Reaction (PCR)
    • Hybridization
    • DNA sequencing
    • Microarray
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Others
  • By Application
    • Infectious diseases
    • Oncology
    • Genetic testing
    • Blood screening
    • Others
  • By Type
    • Instruments
    • Reagents
    • Software & Services
  • By End User
    • Hospital
    • Reference Labortories
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Asia-Pacific
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • ABBOTT LABORATORIES
  • Agilent Technologies Inc.
  • BECTON DICKINSON AND COMPANY
  • BIOMÉRIEUX SA
  • DANAHER CORPORATION
  • F. HOFFMON LA-ROCHE LTD
  • GRIFOLS S.A
  • HOLOGIC INC.
  • QIAGEN INC
  • SIEMENS AG (SIEMENS HEALTHINEERS)
 

Loading Table Of Content...


 
 

Growth of the molecular diagnostic market is attributed to factors, such as technological advancements in the healthcare sector, rise in prevalence of infectious diseases, such as hepatitis, pneumonia, influenza, HIV, and COVID-19, increase in funds from private and government organizations for development of various diagnostic service centers, and rise in awareness about early diagnosis. In addition, increase in awareness and acceptance of personalized medicines and growth in the biomarker identification, further supplement the global molecular diagnostics market growth.

North America is expected to witness the highest growth, in terms of revenue, owing to rise in prevalence of infectious diseases, increase in number of diagnostic tests, and technological advancement of diagnostic instruments in the region.

Asia-Pacific offers profitable opportunities for key players operating in the molecular diagnostics market, thereby registering the fastest growth rate during the forecast period, owing to increase in prevalence of infectious diseases, rise in government initiative for development of advanced diagnostic service, surge in demand for RT-PCR test, and increase in awareness among people for early diagnostic testing.

However, stringent regulatory requirements for the approval of new molecular diagnostics techniques are anticipated to restrain the market growth during the forecast period.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

 Request Sample
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of molecular diagnostics market is $9,160.61 million in 2020.

A. The forcast period for molecular diagnostics market is 2021 to 2030

A. The market value of molecular diagnostics market in 2030 is $23905.56 million.

A. The base year is 2020 in molecular diagnostics market.

A. Top companies such as F. Hoffmann-La Roche AG, BioMérieux SA, Abbott Laboratories, Becton, Dickinson and Company, Qiagen N.V., Danaher Corporation, S.A. held a high market position in 2020.

A. The reagent segment is the most influencing segmentowing to advancement in R&D activities in pharmaceutical & biotechnology industry, increase in demand for reagents, and surge in adoption of point-of-care testing.

A. Increase in the prevalence of the infectious diseases and various types of cancer, drives the growth of the molecular diagnostics market. In addition, increase in awareness and acceptance of personalized medicines, and growth in the biomarker identification further fuel the growth of the market

A. Asia-Pacific is expected to experience the growth rate of 10.78% during the forecast period,owing to the growing healthcare infrastructure, rising disposable incomes, and well-established presence of domestic companies in the region.

A. Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and monitoring response to therapy.

A. Molecular diagnostics used to analyze biological markers in the genome and proteome, and how their cells express their genes as proteins, applying molecular biology to medical testing.

RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Molecular Diagnostics Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,565
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,961
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,939
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,654
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,280
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers